PDL BioPharma, Inc. Net Profit Margin

Net Profit Margin of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Profit Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Net Profit Margin for the quarter ending June 29, 2020 was -958.95% (a 81.22% increase compared to previous quarter)
  • Year-over-year quarterly Net Profit Margin increased by 2281.3%
  • Annual Net Profit Margin for 2019 was -128.59% (a 269.94% increase from previous year)
  • Annual Net Profit Margin for 2018 was -34.76% (a -200.46% decrease from previous year)
  • Annual Net Profit Margin for 2017 was 34.6% (a 32.87% increase from previous year)
  • Twelve month Net Profit Margin ending June 29, 2020 was -297.95% (a 48.01% increase compared to previous quarter)
  • Twelve month trailing Net Profit Margin decreased by -40915.07% year-over-year
Trailing Net Profit Margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-297.95% -201.3% -128.59% 0.73%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Profit Margin of PDL BioPharma, Inc.

Most recent Net Profit Marginof PDLI including historical data for past 10 years.

Interactive Chart of Net Profit Margin of PDL BioPharma, Inc.

PDL BioPharma, Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -958.95% -529.16%
2019 1540.93% -40.27% -59.25% 99.76% -128.59%
2018 36.08% 37.64% -241.11% 4.16% -34.76%
2017 32.83% 33.04% 42.02% 15.94% 34.6%
2016 -15.54% 25.93% 19.71% 54.19% 26.04%
2015 56.48% 55.74% 56.69% 56.44% 56.36%
2014 47.04% 62.11% 56.56% 53.28% 55.44%
2013 52.8% 56.13% 63.12% 58.22% 57.98%
2012 53.47% 56.99% 58.38% 51.95% 55.57%
2011 53.49% 54.81% 57.31% 53.45% 55.07%
2010 -32.13% 46.49% 41.66% 26.63%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.